Thematische Bibliographien / Fibrosis

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte
  6. Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Fibrosis“

Autor: Grafiati
Veröffentlicht am 4. Juni 2021
Zuletzt aktualisiert am 25. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Fibrosis" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Fibrosis"

1

&NA;. "Cystic fibrosis and fibrosing colonopathy." Advances in Anatomic Pathology 3, no. 2 (1996): 112. http://dx.doi.org/10.1097/00125480-199603000-00015.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Smyth, R. L. "Fibrosing colonopathy in cystic fibrosis." Archives of Disease in Childhood 74, no. 5 (1996): 464–68. http://dx.doi.org/10.1136/adc.74.5.464.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Egea-Zorrilla, Alejandro, Zuri馿 Blasco-Iturri, Borja Saez, and Ana Pardo-Saganta. "The Notch3 Pathway in Organ Fibrosis." Fibrosis 2, no. 4 (2024): 10007. http://dx.doi.org/10.70322/fibrosis.2024.10007.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Moreno Diaz, Claudia, Estrella Caballeria, and Jacobo Sellar閟 Torres. "Comparative Analysis of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: Epidemiology, Pathophysiology, Clinical Features, Diagnosis and Treatment." Fibrosis 3, no. 1 (2025): 10001. https://doi.org/10.70322/fibrosis.2025.10001.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Carrino, David A., Sam Mesiano, Nichole M. Barker, William W. Hurd, and Arnold I. Caplan. "Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition." Biochemical Journal 443, no. 2 (2012): 361–68. http://dx.doi.org/10.1042/bj20111996.

Der volle Inhalt der Quelle
Annotation:
Fibrosis is the formation of excess and abnormal fibrous connective tissue as a result of either a reparative or reactive process. A defining feature of connective tissue is its extracellular matrix, which provides structural support and also influences cellular activity. Two common human conditions that result from fibrosis are uterine fibroids (leiomyomas) and keloid scars. Because these conditions share a number of similarities and because their growth is due primarily to excessive extracellular matrix deposition, we compared the proteoglycans of uterine fibroids and keloid scars with corre
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Khan, Khaleque N., Akira Fujishita, Akemi Koshiba, et al. "Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas." PLOS ONE 15, no. 11 (2020): e0242246. http://dx.doi.org/10.1371/journal.pone.0242246.

Der volle Inhalt der Quelle
Annotation:
Differential expressions of estrogen/progesterone receptors (ER/PR) and individual component of extracellular matrices derived from fibroid are reported. Information on the pattern of change in ER/PR expression and amount of tissue fibrosis after hormonal treatment is unclear. We investigated pattern of change in ER/PR expression and percentage of tissue fibrosis in different uterine leiomyomas after gonadotropin-releasing hormone agonist (GnRHa) treatment. Biopsy specimens from fibroids and adjacent myometria were collected after surgery from women with submucosal myoma (SMM, n = 18), intramu
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Sferrazza, Sandro, Marcello Maida, Giulio Calabrese, et al. "The Derivation and External Validation of a Fibrosis Risk Model for Colorectal Tumours Undergoing Endoscopic Submucosal Dissection." Journal of Clinical Medicine 13, no. 15 (2024): 4517. http://dx.doi.org/10.3390/jcm13154517.

Der volle Inhalt der Quelle
Annotation:
Background: Endoscopic submucosal dissection (ESD) is an advanced technique that can become more challenging in the presence of submucosal fibrosis. Predicting the grade of fibrosis is important in order to identify technically difficult ESD. Aims and Methods: Our study aimed to derive and validate a prediction model to determine the preoperative degree of submucosal fibrosis in colorectal tumours undergoing ESD. A predictive model was developed to derive the probability of an increasing submucosal fibrosis in the derivation cohort and then externally validated. Results: 309 patients (age: 68
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Pintér, István, Katalin Vágási, István Wittmann, and Judit Nagy. "Nephrogenic systemic fibrosis." Orvosi Hetilap 148, no. 38 (2007): 1801–4. http://dx.doi.org/10.1556/oh.2007.28183.

Der volle Inhalt der Quelle
Annotation:
A nefrogén szisztémás fibrosis, melyet korábban nefrogén fibrotizáló dermopathiaként említett az irodalom, egy ritka kórkép, mely vesebetegeknél jelentkezik. A kialakulását elsősorban gadolínium alapú MRI-kontrasztanyag alkalmazását követően észlelték beszűkült vesefunkciójú, többnyire dializált betegeken. A nefrogén szisztémás fibrosist a végtagok distalis részén kezdődő, majd a súlyosabb esetekben a tüdőt, májat, szív- és vázizomzatot is érintő fibrosis jellemzi. A betegség több szervrendszer együttes érintettsége esetén – az esetek mintegy 5%-ában – gyors lefolyású és halálos kimenetelű is
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Samokhodskaia, Larisa Mikhaylovna, Ekaterina Evgen'evna Starostina, Elena Borisovna Yarovaya, et al. "Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers." Annals of the Russian academy of medical sciences 70, no. 6 (2015): 651–61. http://dx.doi.org/10.15690/vramn548.

Der volle Inhalt der Quelle
Annotation:
Aim of study. To evaluate clinical significance of different combinations of gene polymorphisms IL-1b, IL-6, IL-10, TNF, HFE, TGF-b, ATR1, NOS3894, CYBA, AGT, MTHFR, FII, FV, FVII, FXIII, ITGA2, ITGB3, FBG, PAI and their prognostic value for prediction of liver fibrosis progression rate in patients with chronic hepatitis C (CHC).Subjects and methods: 118 patients with CHC were divided into «fast» and «slow» (fibrosis rate progression ≥0,13 and 0,13 fibrosis units/yr; n =64 and n =54) fibrosis groups. Gene polymorphisms were determined. Statistical analysis was performed using Statistica 10.Res
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Bertero, Michele, Serena Bainotti, Alberto Comino, et al. "Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis." European Journal of Dermatology 19, no. 1 (2009): 073–74. http://dx.doi.org/10.1684/ejd.2008.0547.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Dissertationen zum Thema "Fibrosis"

1

Enes, Giovana da Silva Tavares 1982. "Fibrose cística = estreitando laços maternos = Cystic fibrosis : strengthening maternal ties." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308361.

Der volle Inhalt der Quelle
Annotation:
Orientador: Antonio Fernando Ribeiro<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas<br>Made available in DSpace on 2018-08-20T12:30:23Z (GMT). No. of bitstreams: 1 Enes_GiovanadaSilvaTavares_M.pdf: 802222 bytes, checksum: 877dccb29eaf785982eed2f02beb39c6 (MD5) Previous issue date: 2012<br>Resumo: A Fibrose Cística é uma doença autossômica recessiva, sistêmica, hereditária, crônica e progressiva e pode levar à morte. São características da doença as secreções mucosas espessas e viscosas que obstrui os ductos das glândulas exócrinas e contribuem pa
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Yi, Hao. "The Effect of Metformin on Inflammatory and Fibrotic Responses in Renal Fibrosis." Thesis, The University of Sydney, 2019. https://hdl.handle.net/2123/21855.

Der volle Inhalt der Quelle
Annotation:
Chronic kidney disease (CKD) is a worldwide public health problem, with adverse outcomes of kidney failure, cardiovascular disease, and premature death. It is well recognised that renal fibrosis is the unifying pathology in almost all forms of progressive CKD. To date, kidney transplantation and dialysis are the only options for the management of end-stage kidney disease, which results in a significant burden on the health system. Hence innovative strategies are needed to both prevent and treat CKD. It is well recognised that inflammatory pathways play a central role in the progression of CKD
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Correia, Cyntia Arivabeni de Araujo. "Estudo dos genes TNF alfa, ADIPOQ e STATH entre portadores de fibrose cistica." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308583.

Der volle Inhalt der Quelle
Annotation:
Orientador: Carmen Silvia Bertuzzo<br>Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-08-13T02:33:23Z (GMT). No. of bitstreams: 1 Correia_CyntiaArivabenideAraujo_D.pdf: 1775265 bytes, checksum: 99ecfece81f00d7833282ae41bae5731 (MD5) Previous issue date: 2009<br>Resumo: A Fibrose Cística (FC) possui uma grande variabilidade de expressão fenotípica, o que significa que crianças com o mesmo genótipo podem diferir quanto à sua apresentação. A proteína defeituosa formada é chamada CFTR (proteína reguladora da conductância iôn
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Chadwick, Helen Kay. "Cognitive function in cystic fibrosis and cystic fibrosis related diabetes (CFRD)." Thesis, University of Leeds, 2016. http://etheses.whiterose.ac.uk/16912/.

Der volle Inhalt der Quelle
Annotation:
Cystic fibrosis (CF) is a complex multisystem disease caused by a gene mutation of a protein called the CF Transmembrane Conductance Regulator (CFTR). Glucose tolerance abnormalities are common in CF and the prevalence of CF related diabetes (CFRD), which shares clinical characteristics with type 1 (T1DM) and type 2 diabetes (T2DM), increases with age. Impaired glucose tolerance (IGT), T1DM and T2DM are associated with cognitive impairment relative to healthy controls. The overall aim of this thesis was to examine cognitive function in CF. Study 1 investigated the impact of CF on cognitive fun
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Karlas, Thomas, Joachim Berger, Nikita Garnov, et al. "Estimating steatosis and fibrosis." Universitätsbibliothek Leipzig, 2015. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-169692.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Katre, Ashwini A. "Ozone and lung fibrosis." Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2009. https://www.mhsl.uab.edu/dt/2009m/katre.pdf.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Kahre, Tiina. "Cystic fibrosis in Estonia /." Online version, 2004. http://dspace.utlib.ee/dspace/bitstream/10062/577/5/KahrePhD.pdf.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Dwyer, Tiffany Jane. "Exercise in cystic fibrosis." Thesis, The University of Sydney, 2010. http://hdl.handle.net/2123/6349.

Der volle Inhalt der Quelle
Annotation:
Exercise and physical activity have many benefits for adults with cystic fibrosis (CF), including the potential to aid mucus clearance, improve lung function, exercise capacity and quality of life. Despite the recommendations from consensus documents for CF adults to engage in regular physical activity, exercise participation amongst this population is often very low. No in-depth study has been undertaken to explore the determinants of exercise participation for this group and no studies have examined the benefits of habitual physical activity on the health status and quality of life of CF adu
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Dwyer, Tiffany Jane. "Exercise in cystic fibrosis." Discipline of Physiotherapy, Faculty of Health Sciences, University of Sydney, 2010. http://hdl.handle.net/2123/6349.

Der volle Inhalt der Quelle
Annotation:
Doctor of Philosophy (PhD)<br>Exercise and physical activity have many benefits for adults with cystic fibrosis (CF), including the potential to aid mucus clearance, improve lung function, exercise capacity and quality of life. Despite the recommendations from consensus documents for CF adults to engage in regular physical activity, exercise participation amongst this population is often very low. No in-depth study has been undertaken to explore the determinants of exercise participation for this group and no studies have examined the benefits of habitual physical activity on the health status
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Utley, Courtney, and Kristen L. McHenry. "Advances in Cystic Fibrosis." Digital Commons @ East Tennessee State University, 2016. https://dc.etsu.edu/etsu-works/2546.

Der volle Inhalt der Quelle
Annotation:
The purpose of this review was to identify the history of and advances in cystic fibrosis (CF). New treatment plans, medication developments, and a historical perspective of airway clearance therapy (ACT) will be presented. The importance of treatment compliance and time management in the care of cystic fibrosis patients will also be discussed. Furthermore, the development of cystic fibrosis clinics and the pivotal role they play in the treatment of the disease will be addressed. Lastly, a brief discussion concerning the need for and process of lung transplantation will be reported.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Bücher zum Thema "Fibrosis"

1

Rittié, Laure, ed. Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

David, Evered, Whelan Julie, Ciba Foundation, and Symposium on Fibrosis (1984 : Ciba Foundation), eds. Fibrosis. Pitman, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Symposium on Fibrosis (1984 : London), ed. Fibrosis. Pitman, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Symposium, Ciba Foundation. Fibrosis. Pitman, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Varga, John, David A. Brenner, and Sem H. Phan, eds. Fibrosis Research. Humana Press, 2005. http://dx.doi.org/10.1385/1592599400.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Silverstein, Alvin. Cystic fibrosis. F. Watts, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Davis, Stephanie Duggins, Margaret Rosenfeld, and James Chmiel, eds. Cystic Fibrosis. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42382-7.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Moss, Richard B., ed. Cystic Fibrosis. Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Amaral, Margarida D., and Karl Kunzelmann, eds. Cystic Fibrosis. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-117-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Amaral, Margarida D., and Karl Kunzelmann, eds. Cystic Fibrosis. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-120-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "Fibrosis"

1

Bährle-Rapp, Marina. "Fibrose, auch: Fibrosis." In Springer Lexikon Kosmetik und Körperpflege. Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_3985.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Rosenbloom, Joel, Edward Macarak, Sonsoles Piera-Velazquez, and Sergio A. Jimenez. "Human Fibrotic Diseases: Current Challenges in Fibrosis Research." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Li, Ian M. H., Amy L. Horwell, Grace Chu, Benoit de Crombrugghe, and George Bou-Gharios. "Characterization of Mesenchymal-Fibroblast Cells Using the Col1a2 Promoter/Enhancer." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_10.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Weiskirchen, Sabine, Carmen G. Tag, Sibille Sauer-Lehnen, Frank Tacke, and Ralf Weiskirchen. "Isolation and Culture of Primary Murine Hepatic Stellate Cells." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_11.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Liew, Lawrence J., Huan Ting Ong, and Rodney J. Dilley. "Isolation and Culture of Adipose-Derived Stromal Cells from Subcutaneous Fat." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_12.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Leavitt, Tripp, Michael S. Hu, and Michael T. Longaker. "Isolation of Live Fibroblasts by Fluorescence-Activated Cell Sorting." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_13.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Puebla-Osorio, Nahum, Seri N. E. Sarchio, Stephen E. Ullrich, and Scott N. Byrne. "Detection of Infiltrating Mast Cells Using a Modified Toluidine Blue Staining." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_14.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Eckes, Beate, Fang Wang, Laure Rittié, Gabriele Scherr, and Paola Zigrino. "Cell-Populated Collagen Lattice Models." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_15.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Xie, Tianfa, Jamar Hawkins, and Yubing Sun. "Traction Force Measurement Using Deformable Microposts." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_16.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Worthen, Christal A., Laure Rittié, and Gary J. Fisher. "Mechanical Deformation of Cultured Cells with Hydrogels." In Fibrosis. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7113-8_17.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Fibrosis"

1

Holmes, Hal, Eli Vlaisavljevich, Ee Lim Tan, Keat G. Ong, and Rupak M. Rajachar. "Magnetoelastic Materials as Novel Bioactive Coatings to Improve Integration of Percutaneous Implants." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53308.

Der volle Inhalt der Quelle
Annotation:
Fibroblastic activity is an innate function of the host response. In the presence of many percutaneous biomedical implants, this activity becomes uncontrollable, resulting in significant fibrous overgrowth at the soft tissue-implant interface [1]. The aberrant cell growth associated with pathological fibrosis can lead to extensive remodeling and excessive synthesis of extracellular matrix (ECM) components, preventing proper integration [2]. Furthermore, these areas of irregular fibrotic activity can also serve as sites for opportunistic infection [3]. In brief, interfacial fibrosis is often re
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Torres Rojas, Aimee M., and Sylvie Lorente. "Vascular Model of Liver Fibrosis." In ASME 2023 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2023. http://dx.doi.org/10.1115/imece2023-112123.

Der volle Inhalt der Quelle
Annotation:
Abstract The liver has a very peculiar blood circulatory system composed of two blood supply vascular trees (the hepatic artery and portal venous networks), microcirculation through small functional units called lobules, and a blood drainage vascular tree (the hepatic vein network). In the healthy liver, flow resistance at the microcirculation level is very low and the portal pressure is almost the same as the lobules pressure. On the other hand, vasculature changes due to fibrosis — located predominantly at the lobules level — lead to a marked increase in resistance to flow causing an increas
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Sewell-Loftin, M. K., and W. David Merryman. "The Role of SRC in Strain- and Ligand- Dependent Phenotypic Modulation of Mouse Embryonic Fibroblasts." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53604.

Der volle Inhalt der Quelle
Annotation:
Connective tissue fibrosis represents a significant portion of mortality and morbidity in our society. These diseases include many illnesses such as heart valve disease, atherosclerosis, macular degeneration, and cirrhosis, meaning that millions of lives are affected by these conditions each year. Fibrotic tissues form when quiescent fibroblasts activate becoming myofibroblasts, the phenotype of active tissue construction and fibrosis. During this process, the cells produce smooth muscle α-actin (αSMA), a contractile element considered to be the hallmark of cellular activation [1]. Following t
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Škrbic, Dusan, Mirna Djuric, Jelena Papovic, and Branislav Tusek. "COVID-19 vaccine and morbidity in the Adult Cystic Fibrosis Centre in Institute for Pulmonary Diseases of Vojvodina Sremska Kamenica, Serbia." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.47.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Petrova, Guergana, Mila Baycheva, Dimitrinka Miteva, et al. "Late diagnosed homozygous delF508 patients - is it really rare?" In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Remus, Natascha, Gaetan Leignadier, Elisa Thomas, et al. "The A-Step - a new incremental exercise test defying space and infection control measures." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.17.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Duplacie, Nele, Trudy Havermans, Janne Houben, et al. "Side-effects and ETI-treatment: a multidisciplinary challenge." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.37.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Daniels, Tanne, Kristel Van Calsteren, and Lieven Dupont. "Maternal and obstetric outcomes in women with cystic fibrosis: a retrospective case series of patients in UZ Leuven." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.31.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Skogeland, Ulrika, Anna Hedborg, Cecilia Rodriguez, Adrienn Bánki, and Tove Godskesen. "Adherence to medical regimens after lung transplantation among adults with Cystic Fibrosis increased during COVID-19 pandemic." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Asir, Nadine, Noor Al-Sulaiti, Abdusamea Shabani, and Atqah Abdul Wahab. "First case of pott's disease in a cystic fibrosis adolescent with a homozygous CFTR mutation c.3700 A > G (p. Ile1234Val)." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.29.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Fibrosis"

1

Liu, Xiaopei, Dan Liu, and Cong’e Tan. Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0133.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: The invasive liver biopsy is the gold standard for the diagnosis of liver cirrhosis. Other non-invasive diagnostic approaches, have been used as alternatives to liver biopsy, however, these methods cannot identify the pathological grade of the lesion. Recently, studies have shown that gut microbiome-based machine learning can be used as a non-invasive diagnostic approach for liver cirrhosis or fibrosis, while it lacks evidence-based support. Therefore, we performed this systematic review and meta-analysis to evaluate its predictive diagnostic value in liver cirrhos
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Hua, Zi Bo, and Lv Yuan Chen. Human UCB MSC versus placebo for effect on kidney fibrosis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0104.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: Human UCB MSC versus placebo for effect on kidney fibrosis Condition being studied: Renal fibrosis is the final outcome of long-term chronic kidney disease, and the kidney will lose its basic function. This experiment will explore the effect of Human UCB MSC for effect on kidney fibrosis. Main outcome(s): Correlation analysis of Human UCB MSC treatment on renalfibrosis.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Hadsall, Katie. Genetic aspects of Pulmonary Fibrosis. Iowa State University, 2020. http://dx.doi.org/10.31274/cc-20240624-784.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Agarwal, Sandeep K. Cadherin-11 Regulation of Fibrosis through Modulation of Epithelial-to-Mesenchymal Transition: Implications for Pulmonary Fibrosis in Scleroderma. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada591380.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Agarwal, Sandeep K. Cadherin-11 Regulation of Fibrosis through Modulation of Epithelial-to-Mesenchymal Transition: Implications for Pulmonary Fibrosis in Scleroderma. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada618226.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco, and Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statist
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Artlett, Carol M. The Modulation of Fibrosis in Scleroderma by 3-Deoxyglucosone. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada485008.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Artlett, Carol M. The Modulation of Fibrosis in Scleroderma by 3-Deoxyglucosone. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada541210.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Artlett, Carol M. The Modulation of Fibrosis in Scleroderma by 3-deoxyglucosone. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada510087.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Garber, Alan, and Joseph Fenerty. Costs and Benefits of Prenatal Screening For Cystic Fibrosis. National Bureau of Economic Research, 1988. http://dx.doi.org/10.3386/w2749.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Fibrosis" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen Bücher
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie